Russian Sputnik V COVID-19 Vaccine Also Claims Over 90% Effectiveness

Dhir Acharya - Nov 11, 2020


Russian Sputnik V COVID-19 Vaccine Also Claims Over 90% Effectiveness

On Monday, Russia stated that its COVID-19 vaccine Sputnik V has an effectiveness rate of over 90%, according to a representative of the health ministry.

On Monday, Russia stated that its COVID-19 vaccine Sputnik V has an effectiveness rate of over 90%, according to a representative of the health ministry.

The representative from the health ministry cited data gathered from vaccinations of the public rather than the ongoing trial, Reuters reported.

Sputnik V is stated to have 90% effectiveness
Sputnik V is stated to have 90% effectiveness

The comments from the Russian representative surfaced after the same statements were made about another COVID-19 vaccine candidate from the US, developed by Pfizer Inc and BioNTech, which said that their vaccine showed over 90% effectiveness rate.

Director Oksana Drapkina of a research institute of the health ministry stated:

“We are responsible for monitoring the effectiveness of the Sputnik V vaccine among citizens who have received it as part of the mass vaccination program. Based on our observations, its effectiveness is also more than 90%. The appearance of another effective vaccine — this is good news for everyone.”

It’s worth noting that Russia has already released its vaccine for domestic use even before completing the third trial phase.

On Monday, Director Alexander Gintsburg of Moscow’s Gamaleya Institute said that welcomed the news about the US vaccine candidate.

“In the near future, we expect to publish interim results of the post-registration trial of the vaccine Sputnik V, the so-called Phase III trials. I am sure that its effectiveness level will also be high.”

The vaccine is being tested on 40,000 people
The vaccine is being tested on 40,000 people

Russia is preparing to release preliminary results of Sputnik V’s Phase III trial, a large-scale test of the vaccine on humans. As of now, the vaccine is being tested on 40,000 people in the country’s capital city, Moscow.

The US is getting closer to having a viable COVID-19 vaccine. At the same time, major countries like the UK and Russia are racing to deliver an effective vaccine as soon as possible.

>>> BREAKING: US COVID-19 Vaccine Suggests Over 90% Effectiveness

Comments

Sort by Newest | Popular

Next Story